1 line
5.6 KiB
JSON
1 line
5.6 KiB
JSON
{"Acne": 3.863900678819783, "Acute polyneuropathy": 18.542161688061253, "Amylase increased": 2.316018006012534, "Anaplastic thyroid cancer": 107.34786695611486, "Aspartate aminotransferase increased": 2.02244397441423, "BRAF V600E mutation positive": 111.68223401325032, "Blindness": 2.314009516060558, "Blindness unilateral": 2.2733837825056304, "Blood albumin decreased": 2.0691707348025967, "Blood calcium increased": 2.576540460546397, "Blood creatine phosphokinase increased": 6.732120148699925, "Blood lactate dehydrogenase increased": 4.526756779370326, "Blood sodium decreased": 2.35731671167896, "Body temperature fluctuation": 3.67200346639987, "Brain neoplasm": 11.370685293800545, "Brain neoplasm malignant": 10.104658395365847, "Brain oedema": 2.9481378578518056, "C-reactive protein increased": 3.319328529838811, "Cardiac dysfunction": 4.443951704125717, "Cardiomyopathy": 3.502203014324529, "Cardiotoxicity": 4.197022043627395, "Cell death": 4.74789447301703, "Central nervous system lesion": 11.909180653404128, "Cerebral disorder": 2.38041950983578, "Cholangitis": 4.813190639270961, "Cholestasis": 4.681211367798367, "Colon cancer": 2.185977507513396, "Concomitant disease aggravated": 3.571072465374731, "Concomitant disease progression": 4.15502629558916, "Cutaneous sarcoidosis": 15.398057463042177, "Death": 4.9989285773258905, "Dehydration": 2.533731390580068, "Dermatitis acneiform": 17.887616917140672, "Disease progression": 3.0865334237674493, "Disseminated intravascular coagulation": 2.3922626869719816, "Drug resistance": 2.038281106331965, "Dry skin": 3.151904218956207, "Dysphagia": 2.480108567082398, "Ejection fraction abnormal": 7.849323766583291, "Ejection fraction decreased": 20.19375858093819, "Electrolyte imbalance": 2.3667273641171405, "Encephalitis": 2.752920009748525, "Erythema nodosum": 21.60531072498026, "Eye disorder": 2.169109793312289, "Fistula": 3.3919802748936925, "General physical health deterioration": 2.0904908754628857, "Glioma": 40.072743996917694, "Haemophagocytic lymphohistiocytosis": 10.826520826364264, "Hepatic cytolysis": 5.372149591942083, "Hepatic enzyme abnormal": 2.605361486140992, "Hepatic lesion": 3.545110952534604, "Hepatitis": 2.3974373304170253, "Hospice care": 10.618065064286146, "Hospitalisation": 2.4543699356278124, "Hyperkeratosis": 5.89885166852538, "Hyperpyrexia": 4.2672086464234935, "Hyperthermia": 5.233498759087492, "Intestinal metastasis": 21.677508070145265, "Intestinal perforation": 3.958823432305798, "Iridocyclitis": 3.4671910377040467, "Left ventricular dysfunction": 2.191451720599213, "Lipase increased": 3.8288939181089487, "Liver disorder": 2.675587149184285, "Liver function test increased": 4.322663492222763, "Lung adenocarcinoma": 20.58901489986512, "Lung adenocarcinoma stage IV": 47.43117599142408, "Lung neoplasm malignant": 7.522788296753413, "Lung opacity": 2.347223800017273, "Lymphocyte count decreased": 3.592330114879607, "Lymphoedema": 3.577902232297576, "Macular oedema": 4.7703811952517565, "Malignant melanoma": 64.0017770057119, "Malignant melanoma stage III": 54.35610889563307, "Malignant melanoma stage IV": 182.91229607400115, "Malignant neoplasm progression": 21.404794520340413, "Malignant pleural effusion": 9.119982180505314, "Melanocytic naevus": 6.214755350681995, "Melanoma recurrent": 153.1431817580438, "Meningitis": 2.3230488546159225, "Metastases to adrenals": 14.582469653935346, "Metastases to bone": 9.652613631305078, "Metastases to bone marrow": 22.575729946073945, "Metastases to central nervous system": 82.49791418944575, "Metastases to kidney": 23.551612640014262, "Metastases to liver": 8.850456318573222, "Metastases to lung": 14.760714822510034, "Metastases to lymph nodes": 18.561362913298435, "Metastases to meninges": 29.598609115839785, "Metastases to peritoneum": 10.155593579182266, "Metastases to skin": 34.28566162207151, "Metastases to spleen": 22.575729946073945, "Metastasis": 23.39653800051764, "Metastatic malignant melanoma": 184.69087549226515, "Metastatic neoplasm": 8.046668306986133, "Neoplasm": 6.161463275336881, "Neutrophil count increased": 3.19258052973548, "Non-small cell lung cancer": 60.309910668213085, "Panniculitis": 33.111360553567046, "Papilloedema": 4.666101138623208, "Paronychia": 3.384080282196391, "Pneumonitis": 3.778139555715681, "Polyneuropathy": 2.3500422255022744, "Product storage error": 2.354352351797106, "Product use in unapproved indication": 5.586566709570676, "Protein total decreased": 6.382971216404859, "Pulmonary mass": 2.807526969748478, "Pyrexia": 3.202486785054562, "Rash maculo-papular": 2.369046197509186, "Rash pustular": 2.5134924073567397, "Recurrent cancer": 14.22219484898548, "Retinal detachment": 13.607838636615742, "Retinal vein occlusion": 3.3326379020841856, "Retinopathy": 4.501384711294162, "Rhabdomyolysis": 5.103568455256867, "Sarcoidosis": 6.375361993792552, "Second primary malignancy": 12.995840973245516, "Serous retinal detachment": 37.017826416601885, "Skin cancer": 2.329583616851272, "Skin lesion": 2.5084289753399736, "Skin mass": 3.648037225245433, "Skin toxicity": 6.580342247647291, "Soft tissue sarcoma": 58.389183700585455, "Squamous cell carcinoma": 4.029436060528416, "Squamous cell carcinoma of skin": 4.640222404996487, "Systemic inflammatory response syndrome": 3.8730848471667856, "Therapy partial responder": 2.9598817827229364, "Thyroid cancer": 4.018593311506203, "Tubulointerstitial nephritis": 2.204870821297397, "Uveitis": 28.60635493784832, "Ventricular hypokinesia": 4.579080932440624, "Vision blurred": 2.207966767052591, "Visual acuity reduced": 2.6032711069643195, "Visual impairment": 3.361474941765595, "Vitiligo": 5.291010753912912, "Vitreous floaters": 3.788368993071226, "Vogt-Koyanagi-Harada disease": 29.866924239522238} |